Data updated: Mar 29, 2026

ZHEJIANG JUTAI PHARM

Neurology

Generics

ZHEJIANG JUTAI PHARM is a generic drug manufacturer focused on Neurology.

2019

Since

3

Drugs

-

Trials

142

Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues ProEarly access

Loading...

Revenue Over Time ProEarly access

Loading...

Recent Activity

BUPROPION HYDROCHLORIDE 2026-02-25

AMANTADINE HYDROCHLORIDE 2025-12-05

BUPROPION HYDROCHLORIDE 2025-11-06

BUPROPION HYDROCHLORIDE 2025-11-06

BUPROPION HYDROCHLORIDE 2025-11-06

BUPROPION HYDROCHLORIDE 2025-11-06

BUPROPION HYDROCHLORIDE 2025-11-06

BUPROPION HYDROCHLORIDE 2025-11-06

SEC Filings ProEarly access

Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Neurology 100%

1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones ProEarly access

Loading...

Patent Cliff ProEarly access

Loading...

Competitors by Therapeutic Area

AbbVie big-pharma

Eli Lilly big-pharma

Roche big-pharma

Bristol-Myers Squibb big-pharma